NCT06312995

Brief Summary

Single-centre, randomised, controlled, non-profit study on a custom-made medical device for immobilisation of radius and ulna fracture in paediatric patients. The aim of the study is to evaluate the benefits in terms of comfort, safety and efficacy resulting from the use of a customised 3D-printed wrist immobilisation device in children aged between 7 and 13 with a fracture of the distal metaphysis of radius or ulna of the 'green stick' type, compared to a control group treated with traditional immobilisation devices. The patients will be randomised between use of customised 3D- printed wrist immobilisisation device and plaster.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 14, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

February 13, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2025

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

2.9 years

First QC Date

February 13, 2024

Last Update Submit

March 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Fracture Healing

    Completion of the therapeutic course, i.e. fracture healing without intervention following immobilisation device placement with residual angulation \< 20°. Radiographic assessment of the fracture angle at 7 and 30 days after application of the device application; * Radiographic assessment of fracture healing at 30 days, defined as presence of bone callus on 3 out of 4 fracture margins; * If at the 7-day assessment the fracture angle appears critical, defined as \>15° or an increase \>5° from the initial radiograph, the patient will undergo a further radiographic assessment after a further 7 days (i.e. 14 days from the start of treatment). * Functional recovery of the limb will be investigated with a clinical examination 30 days after removal of the device (60 from the start of treatment), where arc of motion and elective pain and painability to active mobilisation, as per normal clinical practice.

    At 7 and 30 day from the use of the device

Secondary Outcomes (7)

  • Adverse event

    through study completetion, an average of 1 year

  • Comfort of use of devices

    During the study (at 7 and 30 days from the use of the device)

  • Presence of skin lesions or other manifestations of intolerance to the device

    During the tudy (at 30 days)

  • Pain evaluation

    During the study (7, 30-day and FU)

  • Acceptance of the device

    At 7 and 30 days from the use of the device

  • +2 more secondary outcomes

Study Arms (2)

T3DDY01

EXPERIMENTAL

Acquired a digital acquisition of the patient's forearm using the Intel RealSense D415. The arm of the patient' is placed on a support to allow the plaster nurse to position of the wrist at the correct angle to treat the fracture. The limb is temporarily immobilised in a plaster cast by the nurses of the practice. The patient is booked for a subsequent outpatient visit (which will be conducted within 72 hours of digital acquisition of the forearm) for the application of the device under investigation. The production of the device through a Stratasys F370 3D printer owned by the Meyer Children's Hospital IRCCS. The material used is ABS (Acrylonitrile butadiene styrene) supplied by Stratasys and specific to the machine. Placement of the device on the patient by the investigating nurses, after removal of the temporary device. Collection of data on the evaluation of study parameters.

Device: T3DDY01

PLASTER

ACTIVE COMPARATOR

Traditional device placement (antibrachio-metacarpal cast). Radiological check at 7 days after trauma to verify the angle of the stumps fracture angle, followed by radiological check at 14 days if necessary . Removal of the plaster cast 30 days after the trauma, radiological check to verify the formation of bone callus, clinical evaluation and data collection at the end of treatment

Device: PLASTER

Interventions

T3DDY01DEVICE

Digital acquisition of the patient's forearm using Intel RealSense D415 cameras (CE devices certified according to EN/IEC 60825-1 2007 - Safety of Laser product as Class I Laser Devices, i.e., Non-Hazardous Laser Radiation). The patient's arm is placed on a support to allow the plaster nurse to position the wrist at the correct angle needed to treat the fracture.

T3DDY01
PLASTERDEVICE

Standard treatment plaster for fractures.

PLASTER

Eligibility Criteria

Age7 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patient aged between 7 and 13 years with compound fracture of the distal metaphysis of radius and/or ulna at "green wood" and initial angulation \<20°;
  • Informed consent obtained.

You may not qualify if:

  • Complete fracture of radius and ulna;
  • Open fracture of radius and ulna;
  • Polytrauma, polyfracture;
  • Presence of neurovascular deficit at presentation;
  • Presence of underlying bone disease;
  • Presence of acute or chronic skin disorders;
  • Psycho-behavioural disorders;
  • Presence of ≥1 skin lesions according to NPUAP/EPUAP classification;
  • Specific allergies related to the materials used in the tested device;
  • Inability to perform follow-up examinations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meyer Children's Hospital IRCCS

Florence, 50139, Italy

RECRUITING

MeSH Terms

Conditions

Fractures, Bone

Interventions

Casts, Surgical

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

External FixatorsOrthopedic Fixation DevicesOrthopedic EquipmentSurgical EquipmentEquipment and SuppliesSurgical Fixation Devices

Study Officials

  • Alessandro Zanardi, MD

    Meyer Children's Hospital IRCCS Locations: Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alessandro Zanardi, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 13, 2024

First Posted

March 15, 2024

Study Start

March 14, 2022

Primary Completion

February 14, 2025

Study Completion

June 14, 2025

Last Updated

March 15, 2024

Record last verified: 2024-03

Locations